Intra-Cellular Therapies Secures $70,308,475 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=427cf032-bf72-49ad-ad41-c2e0151e43d0
Date
9/12/2013
Company Name
Intra-Cellular Therapies
Mailing Address
3960 Broadway New York, NY 10032
Company Description
Intra-Cellular Therapies (ITI) is developing novel drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the Central Nervous System (CNS).
Website
http://www.intracellulartherapies.com
Transaction Type
Venture Equity
Transaction Amount
$70,308,475
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
M&A Terms
Venture Investor
Undisclosed